EX-16.1 15 d67753dex161.htm EX-16.1 EX-16.1

Exhibit 16.1



December 22, 2015

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549-7561


We have read the statements made by Intellia Therapeutics, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 11 of Form S-1 as part of the Form S-1 / Amendment No. 2 of Intellia Therapeutics, Inc., dated December 22, 2015. We agree with the statements concerning our firm appearing in such Form S-1.

Very truly yours,

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP

Boston, Massachusetts